IL118493A0 - Delta P62 its variants nucleic acid sequences and their uses - Google Patents

Delta P62 its variants nucleic acid sequences and their uses

Info

Publication number
IL118493A0
IL118493A0 IL11849396A IL11849396A IL118493A0 IL 118493 A0 IL118493 A0 IL 118493A0 IL 11849396 A IL11849396 A IL 11849396A IL 11849396 A IL11849396 A IL 11849396A IL 118493 A0 IL118493 A0 IL 118493A0
Authority
IL
Israel
Prior art keywords
delta
nucleic acid
acid sequences
variants nucleic
variants
Prior art date
Application number
IL11849396A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of IL118493A0 publication Critical patent/IL118493A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL11849396A 1995-06-01 1996-05-30 Delta P62 its variants nucleic acid sequences and their uses IL118493A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506533A FR2734826B1 (fr) 1995-06-01 1995-06-01 Deltap62, ses variants, sequences nucleiques et leurs utilisations

Publications (1)

Publication Number Publication Date
IL118493A0 true IL118493A0 (en) 1996-09-12

Family

ID=9479588

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11849396A IL118493A0 (en) 1995-06-01 1996-05-30 Delta P62 its variants nucleic acid sequences and their uses

Country Status (15)

Country Link
US (1) US6544948B1 (hu)
EP (1) EP0828832A2 (hu)
JP (1) JPH11506325A (hu)
KR (1) KR19990022193A (hu)
AU (1) AU718889B2 (hu)
BR (1) BR9608632A (hu)
CA (1) CA2219861A1 (hu)
CZ (1) CZ291533B6 (hu)
FR (1) FR2734826B1 (hu)
HU (1) HUP9901346A3 (hu)
IL (1) IL118493A0 (hu)
NO (1) NO975409D0 (hu)
SK (1) SK283071B6 (hu)
WO (1) WO1996038556A2 (hu)
ZA (1) ZA964392B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000040606A2 (en) * 1999-01-06 2000-07-13 The Regents Of The University Of California Modulation of hiv replication using sam68
US7479368B2 (en) * 2001-07-30 2009-01-20 G.R.M.O. (Groupe De Recherche En Maladies Osseuses) Inc. Method for detecting subjects having Paget's disease of bone
AU2012294454B2 (en) * 2011-08-08 2017-02-02 Curelab Oncology, Inc. Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
WO2021231652A1 (en) * 2020-05-14 2021-11-18 Curelab Oncology, Inc. Using the p62 plasmid to treat or reduce the severity of coronavirus infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
WO1995002697A1 (fr) * 1993-07-13 1995-01-26 Rhone-Poulenc Rorer S.A. Vecteurs adenoviraux defectifs et utilisation en therapie genique

Also Published As

Publication number Publication date
FR2734826B1 (fr) 1997-07-04
CZ375997A3 (cs) 1998-02-18
AU6129196A (en) 1996-12-18
CZ291533B6 (cs) 2003-03-12
JPH11506325A (ja) 1999-06-08
HUP9901346A3 (en) 2000-10-30
MX9708877A (es) 1998-03-31
ZA964392B (en) 1996-12-09
BR9608632A (pt) 1999-05-04
WO1996038556A2 (fr) 1996-12-05
HUP9901346A2 (hu) 1999-08-30
CA2219861A1 (fr) 1996-12-05
WO1996038556A3 (fr) 1997-01-09
KR19990022193A (ko) 1999-03-25
EP0828832A2 (fr) 1998-03-18
AU718889B2 (en) 2000-04-20
US6544948B1 (en) 2003-04-08
SK283071B6 (sk) 2003-02-04
NO975409L (no) 1997-11-25
SK161397A3 (en) 1998-07-08
FR2734826A1 (fr) 1996-12-06
NO975409D0 (no) 1997-11-25

Similar Documents

Publication Publication Date Title
HK1014561A1 (en) Modified nucleic acid probes
AU6623896A (en) Detection of nucleic acids and nucleic acid units
GB2314508B (en) Diamide-dicarboxylic acid microspheres
IL105874A0 (en) New dna sequences and their uses
AU6042396A (en) Amplification of nucleic acid sequences
AU6667998A (en) Nucleic acids encoding caspase-8h and caspase-8i
IL136349A0 (en) Virulence-associated nucleic acid sequences and uses thereof
NZ286622A (en) Fluorophenylalkenylcarboxylic acid guanidides
AU6057296A (en) DNA sequencing and DNA terminators
GB9516059D0 (en) Novel genes and proteins
AU3979395A (en) DNA sequences and their use
IL123513A0 (en) Identification of bases in nucleic acid sequences
GB9526218D0 (en) DNA Sequences
IL105894A0 (en) Detection of nucleic acid sequences
IL118493A0 (en) Delta P62 its variants nucleic acid sequences and their uses
HUT77435A (hu) Aminosavat tartalmazó nukleotid monomer analógok
EP0830367A4 (en) HIGH AFFINE NUCLEIC ACID LIGANDS BY CYTOKINE
AU6483896A (en) Nucleotide and amino acid sequence and uses thereof
GB9410170D0 (en) Nucleic acid
IL111857A0 (en) Detection of nucleic acid sequences
AU4931196A (en) Nucleic acid polyester polyamides
PL324340A1 (en) Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids
GB9210916D0 (en) Nucleic acid quantification
ZA953597B (en) Plant U14 nucleic acid sequences and derivatives thereof
GB9512092D0 (en) Proteins and nucleic acids